← Leaderboards
C. Henrique Serezani
Vanderbilt University
$10,097,790
Attributed
$12,538,503
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2010–25$2.5M$1.9M$1.3M$625K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,538,503 · 8
By mechanism
R01$7,299,215 · 3
T32$3,661,069 · 1
R00$713,451 · 1
R21$466,660 · 1
K99$242,108 · 1
R03$156,000 · 1
Top collaborators
- Julie A Sterling6 shared
- Digna R Velez Edwards6 shared
Most similar at Vanderbilt University
Same institution · by research overlap
- James Lawrence Wynn$3,920,007
- L Jackson Roberts$17,065,377
- Tina V Hartert$33,847,643
- Avery May Bogart$120,985
- Frederic Tremaine Billings$6,996,810
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularMacrophageInflammationProductionInflammatory ResponseInflammatoryHost DefenseSignal TransductionMediatingReceptorPhagocytesResponseInflammation MediatorsPathogenMyelogenousImmuneEventImmune ResponsePredispositionChronicBaseProgramsLipidsInfection
Grant awards (29)
Hyperglycemia and increased severity to Staphylococcus aureus infections.$685,993
R01 · FY2025 · AI · contact PI
Initiative for Maximizing Student Development (IMSD) at Vanderbilt$523,872
T32 · FY2025 · GM
Initiative for Maximizing Student Development (IMSD) at Vanderbilt$804,635
T32 · FY2024 · GM
Hyperglycemia and increased severity to Staphylococcus aureus infections.$688,727
R01 · FY2024 · AI · contact PI
Initiative for Maximizing Student Development (IMSD) at Vanderbilt$804,388
T32 · FY2023 · GM
Initiative for Maximizing Student Development (IMSD) at Vanderbilt$769,330
T32 · FY2022 · GM
Phosphatase and tensin homolog PTEN actions in polymicrobial sepsis$556,629
R01 · FY2022 · HL · contact PI
Prostaglandin E2 Actions and Enhanced Susceptibility to Skin Infection in Diabetic Mice$507,168
R01 · FY2022 · DK · contact PI
Initiative for Maximizing Student Development (IMSD) at Vanderbilt$32,316
T32 · FY2022 · GM
Initiative for Maximizing Student Development (IMSD) at Vanderbilt$726,528
T32 · FY2021 · GM
Phosphatase and tensin homolog PTEN actions in polymicrobial sepsis$570,731
R01 · FY2021 · HL · contact PI
Prostaglandin E2 Actions and Enhanced Susceptibility to Skin Infection in Diabetic Mice$569,019
R01 · FY2021 · DK · contact PI
Mechanisms underlying poor skin host defense in diabetic conditions$212,080
R21 · FY2021 · AI · contact PI
Prostaglandin E2 Actions and Enhanced Susceptibility to Skin Infection in Diabetic Mice$620,336
R01 · FY2020 · DK · contact PI
Phosphatase and tensin homolog PTEN actions in polymicrobial sepsis$570,731
R01 · FY2020 · HL · contact PI
Mechanisms underlying poor skin host defense in diabetic conditions$254,580
R21 · FY2020 · AI · contact PI
Phosphatase and tensin homolog PTEN actions in polymicrobial sepsis$570,731
R01 · FY2019 · HL · contact PI
Phosphatase and tensin homolog PTEN actions in polymicrobial sepsis$395,000
R01 · FY2018 · HL · contact PI
Phosphatase and tensin homolog PTEN actions in polymicrobial sepsis$395,000
R01 · FY2017 · HL · contact PI
Phosphatase and tensin homolog PTEN actions in polymicrobial sepsis$395,000
R01 · FY2016 · HL · contact PI
LTB4 and the control of methicilin resistant Staphylococcus aureus infection$78,000
R03 · FY2016 · AI · contact PI
Phosphatase and tensin homolog PTEN actions in polymicrobial sepsis$384,150
R01 · FY2015 · HL · contact PI
LTB4 and the control of methicilin resistant Staphylococcus aureus infection$78,000
R03 · FY2015 · AI · contact PI
Phosphatase and tensin homolog PTEN actions in polymicrobial sepsis$390,000
R01 · FY2014 · HL · contact PI
Regulation of Toll-like receptor-induced NFkB activation by Gai-coupled receptors$232,783
R00 · FY2014 · HL · contact PI
Regulation of Toll-like receptor-induced NFkB activation by Gai-coupled receptors$231,668
R00 · FY2013 · HL · contact PI
Regulation of Toll-like receptor-induced NFkB activation by Gai-coupled receptors$249,000
R00 · FY2012 · HL · contact PI
Regulation of Toll-like receptor-induced NFkB activation by Gai-coupled receptors$122,444
K99 · FY2011 · HL · contact PI
Regulation of Toll-like receptor-induced NFkB activation by Gai-coupled receptors$119,664
K99 · FY2010 · HL · contact PI